IN8bio Inc (INAB) USD0.0001

Sell:$2.45Buy:$2.54Price increased$0.18 (7.51%)

Prices delayed by at least 15 minutes
Sell:$2.45
Buy:$2.54
Change:Price increased$0.18 (7.51%)
Prices delayed by at least 15 minutes
Sell:$2.45
Buy:$2.54
Change:Price increased$0.18 (7.51%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
22 December 2025
Emily FairbairnDirector
Buy
Regular purchase transaction
724,637$1.38$999,999.06724,637
22 December 2025
Tai-Wei (William) HoChairman/CEO
Buy
Regular purchase transaction
36,232$1.38$50,000.16121,168
22 December 2025
Peter C BrandtIndependent Director
Buy
Regular purchase transaction
72,464$1.38$100,000.3295,181
22 December 2025
Alan S RoemerChairman of the Board
Buy
Regular purchase transaction
36,232$1.38$50,000.1649,514
22 December 2025
Patrick McCallCFO
Buy
Regular purchase transaction
7,247$1.38$10,000.869,482
22 December 2025
Kate RochlinCOO
Buy
Regular purchase transaction
7,247$1.38$10,000.869,085
2 May 2025
BIOS EQUITY PARTNERS LPVenture Capital
Buy
Regular purchase transaction
1,148,482$0.00$114.851,148,482

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
22 December 2025
Emily FairbairnDirector
Buy
Regular purchase transaction
724,637$1.38$999,999.06724,637
22 December 2025
Peter C BrandtIndependent Director
Buy
Regular purchase transaction
72,464$1.38$100,000.3295,181
22 December 2025
Tai-Wei (William) HoChairman/CEO
Buy
Regular purchase transaction
36,232$1.38$50,000.16121,168
22 December 2025
Alan S RoemerChairman of the Board
Buy
Regular purchase transaction
36,232$1.38$50,000.1649,514
22 December 2025
Patrick McCallCFO
Buy
Regular purchase transaction
7,247$1.38$10,000.869,482

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.